OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:OSUR
- CUSIP: 68554V10
- Web: www.orasure.com
Capitalization:- Market Cap: $1.29265 billion
- Outstanding Shares: 59,459,000
Average Prices:- 50 Day Moving Avg: $20.72
- 200 Day Moving Avg: $16.18
- 52 Week Range: $7.09 - $22.25
P/E:- Trailing P/E Ratio: 40.18
- Foreward P/E Ratio: 54.35
- P/E Growth: 2.25
Sales & Book Value:- Annual Revenue: $135.07 million
- Price / Sales: 9.57
- Book Value: $3.87 per share
- Price / Book: 5.62
Profitability:- EBIDTA: $23.92 million
- Net Margins: 22.29%
- Return on Equity: 15.64%
- Return on Assets: 13.88%
Debt:- Current Ratio: 8.87%
- Quick Ratio: 8.24%
Misc:- Average Volume: 829,338 shs.
- Beta: 1.57
- Short Ratio: 7.16
Frequently Asked Questions for OraSure Technologies (NASDAQ:OSUR)
What is OraSure Technologies' stock symbol?
OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."
How were OraSure Technologies' earnings last quarter?
OraSure Technologies, Inc. (NASDAQ:OSUR) posted its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.09 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.07 by $0.02. The business earned $40.18 million during the quarter, compared to the consensus estimate of $36.54 million. OraSure Technologies had a return on equity of 15.64% and a net margin of 22.29%. The company's revenue was up 28.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.07 earnings per share. View OraSure Technologies' Earnings History.
When will OraSure Technologies make its next earnings announcement?
What guidance has OraSure Technologies issued on next quarter's earnings?
OraSure Technologies updated its third quarter earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of $0.09-0.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.08. The company issued revenue guidance of $40.5-41.5 million, compared to the consensus revenue estimate of $37.64 million.
Where is OraSure Technologies' stock going? Where will OraSure Technologies' stock price be in 2017?
5 brokerages have issued twelve-month target prices for OraSure Technologies' stock. Their forecasts range from $11.00 to $22.00. On average, they anticipate OraSure Technologies' share price to reach $16.65 in the next twelve months. View Analyst Ratings for OraSure Technologies.
Who are some of OraSure Technologies' key competitors?
Some companies that are related to OraSure Technologies include Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Halyard Health (HYH), Inogen (INGN), MiMedx Group (MDXG), CONMED Corporation (CNMD), Asante Solutions (PUMP), Cardiovascular Systems (CSII), K2M Group Holdings (KTWO), Orthofix International N.V. (OFIX), Intersect ENT (XENT), AtriCure (ATRC), CryoLife (CRY), Landauer (LDR), Meridian Bioscience (VIVO), Consort Medical plc (CSRT), Invacare Corporation (IVC) and Antares Pharma (ATRS).
Who are OraSure Technologies' key executives?
OraSure Technologies' management team includes the folowing people:
- Stephen S. Tang Ph.D., Chairman of the Board
- Douglas A. Michels, President, Chief Executive Officer, Director
- Ronald H. Spair, Chief Financial Officer, Chief Operating Officer, Director
- Anthony II Zezzo II, Executive Vice President - Marketing and Sales
- Mark L. Kuna, Senior Vice President - Finance, Controller, Assistant Secretary
- Michael Reed Ph.D., Senior Vice President - Research and Development, Chief Scientific Officer
- Jack E. Jerrett, Senior Vice President, General Counsel, Secretary
- Mara Glickman Aspinall, Director
- Eamonn P. Hobbs, Director
- Michael Celano, Independent Director
Who owns OraSure Technologies stock?
OraSure Technologies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.61%), Vanguard Group Inc. (9.15%), Renaissance Technologies LLC (8.73%), Dimensional Fund Advisors LP (5.23%), Daruma Capital Management LLC (4.75%) and Acadian Asset Management LLC (3.20%). Company insiders that own OraSure Technologies stock include Anthony Zezzo II, Brian Smith, Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair, Ronny B Lancaster and Stephen S Phd Tang. View Institutional Ownership Trends for OraSure Technologies.
Who sold OraSure Technologies stock? Who is selling OraSure Technologies stock?
OraSure Technologies' stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, JPMorgan Chase & Co., Thrivent Financial For Lutherans, BlackRock Inc., Cornerstone Capital Management Holdings LLC., Prudential Financial Inc., Alliancebernstein L.P. and Globeflex Capital L P. Company insiders that have sold OraSure Technologies stock in the last year include Anthony Zezzo II, Brian Smith, Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair, Ronny B Lancaster and Stephen S Phd Tang. View Insider Buying and Selling for OraSure Technologies.
Who bought OraSure Technologies stock? Who is buying OraSure Technologies stock?
OraSure Technologies' stock was bought by a variety of institutional investors in the last quarter, including Daruma Capital Management LLC, Vanguard Group Inc., Acadian Asset Management LLC, Columbus Circle Investors, Public Employees Retirement System of Ohio, Russell Investments Group Ltd., Intrinsic Edge Capital Management LLC and Federated Investors Inc. PA. View Insider Buying and Selling for OraSure Technologies.
How do I buy OraSure Technologies stock?
Shares of OraSure Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is OraSure Technologies' stock price today?
One share of OraSure Technologies stock can currently be purchased for approximately $21.74.
MarketBeat Community Rating for OraSure Technologies (NASDAQ OSUR)MarketBeat's community ratings are surveys of what our community members think about OraSure Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for OraSure Technologies (NASDAQ:OSUR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 5 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $16.65 (23.41% downside) |
Analysts' Ratings History for OraSure Technologies (NASDAQ:OSUR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/19/2017 | Canaccord Genuity | Reiterated Rating | Buy | $22.00 | Low |  |
| 9/12/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $20.00 | Low | |
| 7/11/2017 | Stephens | Reiterated Rating | Overweight | $14.00 -> $19.00 | Low | |
| 2/9/2017 | Raymond James Financial, Inc. | Upgrade | Market Perform -> Outperform | $11.25 | N/A | |
| 12/20/2016 | CL King | Initiated Coverage | Buy | $11.00 | N/A | |
| 9/19/2016 | BTIG Research | Downgrade | Buy -> Neutral | $8.00 | N/A | |
| 7/5/2016 | Mizuho | Reiterated Rating | Outperform | $8.00 | N/A | |
(Data available from 9/25/2015 forward)
Earnings History for OraSure Technologies (NASDAQ:OSUR)Earnings History by Quarter for OraSure Technologies (NASDAQ OSUR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/31/2017 | | $0.08 | | | | | N/A | |
| 8/2/2017 | Q2 2017 | $0.07 | $0.09 | $36.54 million | $40.18 million | View | Listen | |
| 5/3/2017 | Q1 2017 | $0.17 | $0.21 | $31.19 million | $32.55 million | View | Listen | |
| 2/8/2017 | Q4 2016 | $0.06 | $0.13 | $34.80 million | $35.50 million | View | Listen | |
| 11/2/2016 | Q316 | $0.07 | $0.11 | $31.45 million | $32.25 million | View | Listen | |
| 8/3/2016 | Q216 | $0.05 | $0.07 | $31.15 million | $31.36 million | View | Listen | |
| 5/4/2016 | Q1 | $0.02 | $0.04 | $28.82 million | $29.10 million | View | Listen | |
| 2/3/2016 | Q4 | $0.03 | $0.08 | $29.73 million | $32.38 million | View | Listen | |
| 11/4/2015 | Q315 | ($0.01) | $0.03 | $29.58 million | $29.90 million | View | Listen | |
| 8/5/2015 | Q215 | $0.01 | $0.03 | $28.95 million | $30.34 million | View | Listen | |
| 2/4/2015 | Q414 | ($0.04) | ($0.05) | $28.22 million | $28.68 million | View | Listen | |
| 11/5/2014 | Q314 | ($0.05) | $0.02 | $27.20 million | $27.85 million | View | Listen | |
| 8/6/2014 | Q214 | ($0.04) | $0.04 | $26.21 million | $26.40 million | View | Listen | |
| 5/7/2014 | Q114 | ($0.13) | ($0.10) | $23.28 million | $23.50 million | View | Listen | |
| 2/5/2014 | Q413 | ($0.08) | $0.11 | $27.43 million | $28.80 million | View | Listen | |
| 11/6/2013 | Q313 | ($0.10) | ($0.03) | $24.21 million | $24.70 million | View | Listen | |
| 8/7/2013 | Q2 2013 | ($0.16) | ($0.10) | $23.67 million | $24.30 million | View | Listen | |
| 5/8/2013 | Q1 2013 | ($0.18) | ($0.18) | $20.82 million | $21.20 million | View | Listen | |
| 2/6/2013 | Q4 2012 | ($0.14) | ($0.11) | $20.87 million | $22.14 million | View | Listen | |
| 11/7/2012 | Q312 | ($0.07) | ($0.04) | $22.26 million | $22.10 million | View | N/A | |
| 8/7/2012 | | ($0.08) | ($0.07) | | | View | N/A | |
| 5/2/2012 | | ($0.09) | ($0.07) | | | View | N/A | |
| 11/2/2011 | | ($0.07) | ($0.03) | | | View | N/A | |
| 8/3/2011 | | ($0.05) | ($0.05) | | | View | N/A | |
| 5/5/2011 | | ($0.08) | ($0.06) | | | View | N/A | |
| 2/9/2011 | | ($0.08) | ($0.02) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for OraSure Technologies (NASDAQ:OSUR)2017 EPS Consensus Estimate: $0.42
2018 EPS Consensus Estimate: $0.41
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.17 | $0.17 | $0.17 |
| Q2 2017 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2017 | 1 | $0.09 | $0.09 | $0.09 |
| Q4 2017 | 1 | $0.09 | $0.09 | $0.09 |
| Q1 2018 | 1 | $0.09 | $0.09 | $0.09 |
| Q2 2018 | 1 | $0.11 | $0.11 | $0.11 |
| Q3 2018 | 1 | $0.11 | $0.11 | $0.11 |
| Q4 2018 | 1 | $0.10 | $0.10 | $0.10 |
(Data provided by Zacks Investment Research)
Dividend History for OraSure Technologies (NASDAQ:OSUR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for OraSure Technologies (NASDAQ:OSUR)Insider Ownership Percentage: 6.40%
Institutional Ownership Percentage: 92.10%
Insider Trades by Quarter for OraSure Technologies (NASDAQ:OSUR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/31/2017 | Brian Smith | Insider | Sell | 9,112 | $20.47 | $186,522.64 | |
| 8/30/2017 | Charles W Patrick | Director | Sell | 1,000 | $20.11 | $20,110.00 | |
| 8/22/2017 | Brian Smith | Insider | Sell | 3,075 | $21.09 | $64,851.75 | |
| 8/7/2017 | Anthony Zezzo II | EVP | Sell | 72,916 | $21.26 | $1,550,194.16 | |
| 8/7/2017 | Jack E Jerrett | SVP | Sell | 73,463 | $20.77 | $1,525,826.51 | |
| 8/7/2017 | Ronald H Spair | CFO | Sell | 510,112 | $20.66 | $10,538,913.92 | |
| 6/27/2017 | Douglas A Michels | CEO | Sell | 290,495 | $16.75 | $4,865,791.25 | |
| 5/30/2017 | Ronny B Lancaster | Director | Sell | 89,684 | $14.79 | $1,326,426.36 | |
| 5/10/2017 | Anthony Zezzo II | EVP | Sell | 115,000 | $14.70 | $1,690,500.00 | |
| 5/9/2017 | Douglas A Michels | CEO | Sell | 209,800 | $15.01 | $3,149,098.00 | |
| 5/8/2017 | Douglas A Michels | CEO | Sell | 361,216 | $15.08 | $5,447,137.28 | |
| 5/8/2017 | Mark L Kuna | SVP | Sell | 36,413 | $15.11 | $550,200.43 | |
| 5/8/2017 | Ronald H Spair | CFO | Sell | 72,564 | $15.00 | $1,088,460.00 | |
| 5/5/2017 | Michael Celano | Director | Sell | 44,962 | $14.95 | $672,181.90 | |
| 3/21/2017 | Stephen S Phd Tang | Director | Sell | 220 | $12.00 | $2,640.00 | |
| 2/28/2017 | Charles W Patrick | Director | Sell | 29,883 | $11.29 | $337,379.07 | |
| 2/16/2017 | Ronald H Spair | CFO | Sell | 50,000 | $11.12 | $556,000.00 | |
| 2/15/2017 | Jack E Jerrett | SVP | Sell | 107,288 | $11.06 | $1,186,605.28 | |
| 2/15/2017 | Stephen S Phd Tang | Director | Sell | 40,000 | $11.04 | $441,600.00 | |
| 2/14/2017 | Ronald H Spair | CFO | Sell | 63,720 | $10.60 | $675,432.00 | |
| 2/10/2017 | Mark L Kuna | SVP | Sell | 79,271 | $10.61 | $841,065.31 | |
| 1/31/2017 | Michael Celano | Director | Sell | 15,000 | $8.78 | $131,700.00 | |
| 1/17/2017 | Ronald H Spair | CFO | Sell | 3,341 | $8.71 | $29,100.11 | |
| 12/15/2016 | Mark L Kuna | SVP | Sell | 10,000 | $9.30 | $93,000.00 | |
| 12/13/2016 | Douglas A Michels | CEO | Sell | 71,466 | $9.07 | $648,196.62 | |
| 12/13/2016 | Mark L Kuna | SVP | Sell | 17,000 | $9.11 | $154,870.00 | |
| 12/9/2016 | Mark L Kuna | SVP | Sell | 3,000 | $9.03 | $27,090.00 | |
| 11/23/2016 | Douglas A Michels | CEO | Sell | 30,893 | $9.02 | $278,654.86 | |
| 11/23/2016 | Jack E Jerrett | SVP | Sell | 24,000 | $9.00 | $216,000.00 | |
| 9/26/2016 | Douglas A Michels | CEO | Sell | 25,000 | $8.22 | $205,500.00 | |
| 8/31/2016 | Charles W Patrick | Director | Sell | 17,483 | $8.58 | $150,004.14 | |
| 8/30/2016 | Jack E Jerrett | SVP | Sell | 68,686 | $8.52 | $585,204.72 | |
| 8/29/2016 | Charles W Patrick | Director | Sell | 2,250 | $8.94 | $20,115.00 | |
| 8/5/2016 | Charles W Patrick | Director | Sell | 6,575 | $7.24 | $47,603.00 | |
| 12/19/2014 | Ronald H Spair | CFO | Sell | 75,974 | $10.01 | $760,499.74 | |
| 12/9/2014 | Ronald H Spair | CFO | Sell | 1,026 | $10.00 | $10,260.00 | |
| 12/8/2014 | Ronald H Spair | CFO | Sell | 126 | $10.00 | $1,260.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for OraSure Technologies (NASDAQ:OSUR)
Latest Headlines for OraSure Technologies (NASDAQ:OSUR)
| Source: |
|
| Date | Headline |
|---|
 | OraSure Technologies, Inc. (OSUR) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - September 24 at 3:24 PM |
 | Medical Devices Are The Quiet Growth Sector | Seeking Alpha - Seeking Alpha
seekingalpha.com - September 22 at 7:52 AM |
| OraSure Technologies, Inc. (OSUR) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - September 20 at 9:02 AM |
 | OraSure Technologies to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
feeds.benzinga.com - September 20 at 6:55 AM |
| OraSure Technologies, Inc. (OSUR) Given Buy Rating at Canaccord Genuity
www.americanbankingnews.com - September 19 at 5:48 PM |
| Comparing OraSure Technologies (OSUR) and Landauer (LDR)
www.americanbankingnews.com - September 19 at 4:14 AM |
| OraSure Technologies (OSUR) Presents At CL King 15th Annual Best Ideas Conference - Slideshow
seekingalpha.com - September 16 at 7:29 AM |
 | ETFs with exposure to OraSure Technologies, Inc. : September 13, 2017
finance.yahoo.com - September 14 at 8:52 AM |
| OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q2, 2017 By the Numbers : September 12, 2017
finance.yahoo.com - September 13 at 7:33 AM |
| Analyzing OraSure Technologies (OSUR) and Its Rivals
www.americanbankingnews.com - September 12 at 10:22 PM |
| 5 Top-Ranked MedTech Growth Stocks for Solid Returns - Yahoo Finance
finance.yahoo.com - September 12 at 8:21 AM |
| OraSure Technologies, Inc. (OSUR) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - September 9 at 8:52 PM |
| Zacks Investment Research Upgrades OraSure Technologies, Inc. (OSUR) to "Buy"
www.americanbankingnews.com - September 9 at 6:14 AM |
| Zacks: Analysts Expect OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $40.82 Million
www.americanbankingnews.com - September 8 at 11:10 AM |
| OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference
finance.yahoo.com - September 6 at 7:19 AM |
| OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference
finance.yahoo.com - September 6 at 7:19 AM |
| OraSure Technologies to Present at CL King's 15th Annual Best Ideas Conference
feeds.benzinga.com - September 6 at 6:46 AM |
| Zacks: Brokerages Anticipate OraSure Technologies, Inc. (OSUR) Will Post Earnings of $0.09 Per Share
www.americanbankingnews.com - September 6 at 2:06 AM |
| OraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - September 5 at 6:44 PM |
| Brian Smith Sells 9,112 Shares of OraSure Technologies, Inc. (OSUR) Stock
www.americanbankingnews.com - September 5 at 4:26 PM |
| OraSure Technologies, Inc. (OSUR) Director Charles W. Patrick Sells 1,000 Shares
www.americanbankingnews.com - August 31 at 8:00 PM |
 | Orthofix (OFIX) is a Great Momentum Pick for You: Here's Why - Nasdaq
www.nasdaq.com - August 29 at 6:28 AM |
| OraSure Technologies, Inc. (OSUR) Insider Brian Smith Sells 3,075 Shares
www.americanbankingnews.com - August 24 at 7:56 PM |
| Can OraSure (OSUR) Run Higher on Strong Earnings Estimate Revisions? - Nasdaq
www.nasdaq.com - August 23 at 9:58 AM |
| Can OraSure (OSUR) Run Higher on Strong Earnings Estimate Revisions?
finance.yahoo.com - August 22 at 2:49 AM |
| Analyzing OraSure Technologies (OSUR) & Syneron Medical (ELOS)
www.americanbankingnews.com - August 21 at 2:10 AM |
| Brokerages Expect OraSure Technologies, Inc. (OSUR) to Post $0.09 Earnings Per Share
www.americanbankingnews.com - August 18 at 2:22 PM |
| OraSure Technologies, Inc. (NASDAQ:OSUR) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 11 at 6:48 PM |
| Anthony Zezzo II Sells 72,916 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) Stock
www.americanbankingnews.com - August 9 at 7:52 PM |
| Insider Selling: OraSure Technologies, Inc. (OSUR) SVP Sells 73,463 Shares of Stock
www.americanbankingnews.com - August 8 at 7:24 PM |
| OraSure Technologies, Inc. (OSUR) CFO Sells $10,538,913.92 in Stock
www.americanbankingnews.com - August 8 at 7:24 PM |
| Validea Motley Fool Strategy Daily Upgrade Report - 8/4/2017 - Nasdaq
www.nasdaq.com - August 5 at 9:08 PM |
| Q3 2017 Earnings Forecast for OraSure Technologies, Inc. (OSUR) Issued By Jefferies Group
www.americanbankingnews.com - August 4 at 7:22 AM |
| OraSure Technologies, Inc. (NASDAQ:OSUR) Price Target Raised to $22.00 at Canaccord Genuity
www.americanbankingnews.com - August 3 at 6:06 PM |
 | OraSure Announces 2017 Second Quarter Financial Results - GlobeNewswire (press release)
globenewswire.com - August 3 at 6:44 AM |
| OraSure Announces 2017 Second Quarter Financial Results
finance.yahoo.com - August 3 at 6:44 AM |
| Edited Transcript of OSUR earnings conference call or presentation 2-Aug-17 9:00pm GMT
finance.yahoo.com - August 3 at 6:44 AM |
| OraSure posts 2Q profit
finance.yahoo.com - August 3 at 6:44 AM |
| OraSure Technologies, Inc. (NASDAQ:OSUR) Updates Q3 Earnings Guidance
www.americanbankingnews.com - August 2 at 9:02 PM |
| Zacks: Brokerages Expect OraSure Technologies, Inc. (NASDAQ:OSUR) Will Post Quarterly Sales of $36.55 Million
www.americanbankingnews.com - August 2 at 8:30 AM |
| OraSure Technologies to Present at the Canaccord Genuity 37th Annual Growth Conference
finance.yahoo.com - August 2 at 6:41 AM |
| OraSure Technologies to Present at the Canaccord Genuity 37th Annual Growth Conference
finance.yahoo.com - August 2 at 6:41 AM |
| Brokerages Anticipate OraSure Technologies, Inc. (NASDAQ:OSUR) to Announce $0.07 Earnings Per Share
www.americanbankingnews.com - July 31 at 10:31 AM |
 | OraSure Technologies (OSUR) OraQuick HIV Self-Test Selected by ... - StreetInsider.com
www.streetinsider.com - July 25 at 12:34 AM |
| OraQuick® HIV Self-Test Selected for Next Phase of STAR Project for HIV Self-Testing in Africa
finance.yahoo.com - July 24 at 2:31 PM |
| OraSure's HIV Self-Test prequalified by WHO - Seeking Alpha
seekingalpha.com - July 22 at 7:21 AM |
| OraSure Technologies Receives World Health Organization Prequalification of OraQuick® HIV Self-Test
finance.yahoo.com - July 22 at 7:21 AM |
| OraSure Technologies, Inc. (OSUR) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 17 at 6:40 PM |
 | Today's Research Report Coverage on Medical Supplies Stocks -- OraSure Technologies, DENTSPLY SIRONA, Baxter Intl., and Glaukos
www.prnewswire.com - July 14 at 7:13 AM |
 | Here's What Lifted OraSure Technologies, Inc. 12.1% in June - Motley Fool
www.fool.com - July 12 at 6:41 AM |
OraSure Technologies (OSUR) Chart for Monday, September, 25, 2017
